Does UPADACITINIB Cause Myelosuppression? 13 Reports in FDA Database

Q: Does UPADACITINIB cause Myelosuppression?

13 reports of Myelosuppression have been filed with the FDA for UPADACITINIB, representing 0.0% of all UPADACITINIB adverse event reports.

Q: How dangerous is Myelosuppression from UPADACITINIB?

Of 13 reports, 1 (7.7%) resulted in death and 3 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Myelosuppression have been filed in association with UPADACITINIB (Rinvoq). This represents 0.0% of all adverse event reports for UPADACITINIB.

Reports of Myelosuppression with UPADACITINIB

0.0%

of all UPADACITINIB reports

Deaths

Hospitalizations

How Dangerous Is Myelosuppression From UPADACITINIB?

Of the 13 reports, 1 (7.7%) resulted in death, 3 (23.1%) required hospitalization.

Is Myelosuppression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does UPADACITINIB Cause?

Pain (4,444) Arthralgia (3,815) Drug ineffective (3,384) Covid-19 (2,978) Rheumatoid arthritis (2,730) Pain in extremity (2,353) Fatigue (2,153) Fall (2,081) Surgery (2,037) Therapy interrupted (1,741)

What Other Drugs Cause Myelosuppression?

CYCLOPHOSPHAMIDE (3,603) CARBOPLATIN (2,624) TRASTUZUMAB (2,552) PACLITAXEL (2,522) TISLELIZUMAB (2,142) CYTARABINE (1,869) VENETOCLAX (1,864) CISPLATIN (1,849) BEVACIZUMAB (1,744) SODIUM (1,696)

Which UPADACITINIB Alternatives Have Lower Myelosuppression Risk?

UPADACITINIB vs URAPIDIL UPADACITINIB vs UREA UPADACITINIB vs URIDINE TRIACETATE UPADACITINIB vs UROFOLLITROPIN UPADACITINIB vs URSODIOL

UPADACITINIB Full Profile All Myelosuppression Reports All Drugs Causing Myelosuppression UPADACITINIB Demographics